These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 9266021

  • 1. The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behçet's disease.
    Wang LM, Kitteringham N, Mineshita S, Wang JZ, Nomura Y, Koike Y, Miyashita E.
    Arch Dermatol Res; 1997 Jul; 289(8):444-7. PubMed ID: 9266021
    [Abstract] [Full Text] [Related]

  • 2. Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease.
    Freire Ade L, Bertolo MB, de Pinho AJ, Samara AM, Fernandes SR.
    Clin Rheumatol; 2004 Jun; 23(3):203-5. PubMed ID: 15168145
    [Abstract] [Full Text] [Related]

  • 3. Investigating the role of IL-33 in the pathogenesis of Behçet's Disease.
    Çerçi P, Altıner S, İnal A, Köse K, Keskin G, Ölmez Ü.
    Acta Clin Belg; 2017 Dec; 72(6):434-438. PubMed ID: 28412856
    [Abstract] [Full Text] [Related]

  • 4. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ, Park JS, Kang MI, Lee SK, Park YB, Lee SW.
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [Abstract] [Full Text] [Related]

  • 5. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili-Boussen I, Haj-Sassi F.
    Clin Exp Rheumatol; 2013 Dec; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [Abstract] [Full Text] [Related]

  • 6. Interactions of nitric oxide and superoxide dismutase in Behçet's disease.
    Kiraz S, Ertenli I, Calgüneri M, Oztürk MA, Haznedaroglu IC, Altun B, Erman M, Celik I.
    Clin Exp Rheumatol; 2001 Dec; 19(5 Suppl 24):S25-9. PubMed ID: 11760394
    [Abstract] [Full Text] [Related]

  • 7. Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells.
    Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis P, Orfanos CE.
    Arch Dermatol Res; 2000 Jun; 292(6):279-84. PubMed ID: 10929768
    [Abstract] [Full Text] [Related]

  • 8. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
    Fawzy RM, Said EA, Mohamed SM, Fouad NA, Akl EM.
    Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
    [Abstract] [Full Text] [Related]

  • 9. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
    Evereklioglu C, Er H, Türköz Y, Cekmen M.
    Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
    [Abstract] [Full Text] [Related]

  • 10. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
    Aki T, Karincaoglu Y, Seyhan M, Batcioglu K.
    Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
    [Abstract] [Full Text] [Related]

  • 11. Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Behçet's disease with and without ocular disease.
    Aydin E, Sögüt S, Ozyurt H, Ozugurlu F, Akyol O.
    Ophthalmic Res; 2004 Jul; 36(3):177-82. PubMed ID: 15103210
    [Abstract] [Full Text] [Related]

  • 12. Plasma and whole-blood chemokine levels in patients with Behcet's disease.
    Kaburaki T, Fujino Y, Kawashima H, Merino G, Numaga J, Chen J, Matsushima K.
    Graefes Arch Clin Exp Ophthalmol; 2003 May; 241(5):353-8. PubMed ID: 12712358
    [Abstract] [Full Text] [Related]

  • 13. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP, Ulkar GB, Eskioglu F, Tatlican S, Mert A, Akgul A.
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [Abstract] [Full Text] [Related]

  • 14. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A.
    Clin Exp Rheumatol; 2007 Mar; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
    Buldanlioglu S, Turkmen S, Ayabakan HB, Yenice N, Vardar M, Dogan S, Mercan E.
    Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
    [Abstract] [Full Text] [Related]

  • 16. Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.
    Chekaoui A, Lahmar K, Belguendouz H, Mazari F, Terahi M, Hakem D, Youinou P, Touil-Boukoffa C.
    Eur Cytokine Netw; 2018 Sep 01; 29(3):95-102. PubMed ID: 30547891
    [Abstract] [Full Text] [Related]

  • 17. Serum oxidant/antioxidant status in patients with Behçet's disease.
    Taysi S, Kocer I, Memisogullari R, Kiziltunc A.
    Ann Clin Lab Sci; 2002 Sep 01; 32(4):377-82. PubMed ID: 12458889
    [Abstract] [Full Text] [Related]

  • 18. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
    Keskin D, Keskin G, Inal A, Ozışık L.
    Acta Clin Belg; 2014 Aug 01; 69(4):246-50. PubMed ID: 25012748
    [Abstract] [Full Text] [Related]

  • 19. IL-38 serum levels in patients with Behcet's disease and the relationship with clinical features.
    Zarrabi M, Gholijani N, Shenavandeh S, Aflaki E, Amirghofran Z.
    Eur Cytokine Netw; 2019 Sep 01; 30(3):82-87. PubMed ID: 31957702
    [Abstract] [Full Text] [Related]

  • 20. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K, Evereklioglu C, Cekmen M, Ozkiris A, Duygulu F, Dogan H.
    Mediators Inflamm; 2003 Apr 01; 12(2):107-16. PubMed ID: 12775361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.